東京大学医学部医学科

Angiotensin II-induced phosphorylation of the sodium chloride cotransporter.
共著, Tanemoto M, Uchida S., Kidney Int. 2011 Jun;79(12):1381-1382., 2011年06月

Differential Diagnosis of Chronic Kidney Disease (CKD): By primary diseases.
単著, 筆頭著者, Uchida S., JMAJ 2011;54: 22?26., 2011年11月

Urinary stone analysis in a patient with hyperuricemia to determine the mechanism of stone formation.
共著, Kaneko K, Yoshida N, Okazaki K, Yamanobe T, Yamaoka N, Yasuda M, Ogata N, Yamada Y, Uchida S, Fujimori S., Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1072-6., 2011年12月

Nicorandil, a K(atp) channel opener, alleviates chronic renal injury by targeting podocytes and macrophages.
共著, Tamura Y, Tanabe K, Kitagawa W, Uchida S, Schreiner GF, Johnson RJ, Nakagawa T., Am J Physiol - Renal Physiol. 2012 Aug 1;303(3):F339-F349., 2012年08月

Primary polydipsia, but not accumulated ceramide, causes lethal renal damage in saposin D-deficient mice.
共著, Hisaki H, Matsuda J, Tadano-Aritomi K, Uchida S, Okinaga H, Miyagawa M, Tamamori-Adachi M, Iizuka M, Okazaki T., Am J Physiol - Renal Physiol. 2012 Oct;303(7):F1049-F1059., 2012年10月

Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR).
共著, Yokoyama H, Sugiyama H, Sato H, Taguchi T, Nagata M, Matsuo S, Makino H, Watanabe T, Saito T, Kiyohara Y, Nishi S, Iida H, Morozumi K, Fukatsu A, Sasaki T, Tsuruya K, Kohda Y, Higuchi M, Kiy, Clin Exp Nephrol. 2012 Dec;16(6):903-20., 2012年12月

The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gou
共著, Hosoya T, Kimura K, Itoh S, Inaba M, Uchida S, Tomino Y, Makino H, Matsuo S, Yamamoto T, Ohno I, Shibagaki Y, Iimuro S, Imai N, Kuwabara M, Hayakawa H., Trials. 2014 Jan 16;15:26., 2014年01月

Uric acid transporter ABCG2 is increased in the intestine of the 5/6 nephrectomy rat model of chronic kidney disease.
共著, Yano H, Tamura Y, Kobayashi K, Tanemoto M, Uchida S., Clin Exp Nephrol. 2014 Feb;18(1):50-5., 2014年02月

Mislocalization of K+ channels causes the renal salt wasting in EAST/SeSAME syndrome.
共著, Tanemoto M, Abe T, Uchida S, Kawahara K., FEBS Lett. 2014 Mar 18;588(6):899-905., 2014年03月

A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease.
共著, Wada T, Nangaku M, Maruyama S, Imai E, Shoji K, Kato S, Endo T, Muso E, Kamata K, Yokoyama H, Fujimoto K, Obata Y, Nishino T, Kato H, Uchida S, Sasatomi Y, Saito T, Matsuo S., Kidney Int. 2014 Mar;85(3):641-648., 2014年03月

Proteomic analysis to examine the role of matrix proteins in a gouty tophus from a patient with recurrent gout.
共著, Kaneko K, Iwamoto H, Yasuda M, Inazawa K, Yamaoka N, Fukuuchi T, Tamura Y, Uchida S, Mawatari K, Nakagomi K, Yamada Y, Fujimori S., Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):199-207., 2014年06月

Clinical Image. Lack of blood flow in bilateral renal cortex.
共著, Asakawa S, Tanemoto M, Kawamorita Y, Okura R, Fujigaki Y, Uchida S., JSM Clin Case Rep. 2014 Sep 29;2(5): 1054., 2014年09月

Angiotensin II signaling via protein kinase C phosphorylates Kelch-like 3, preventing WNK4 degradation.
共著, Shibata S, Arroyo JP, Casta?eda-Bueno M, Puthumana J, Zhang J, Uchida S, Stone KL, Lam TT, Lifton RP., Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15556-15561., 2014年10月

Effects of the N/L-Type calcium channel blocker cilnidipine on nephropathy and uric acid metabolism in hypertensive patients wi
共著, Uchida S, Takahashi M, Sugawara M, Saito T, Nakai K, Fujita M, Mochizuki K, Shin I, Morita T, Hikita T, Itakura H, Takahashi Y, Mizuno S, Ohno Y, Ito K, Ito T, Soma M., J Clin Hypertens (Greenwich). 2014 Oct;16(10):746-753., 2014年10月

Successful treatment of infectious endocarditis associated glomerulonephritis mimicking C3 glomerulonephritis in a case with no
共著, Kawamorita Y, Fujigaki Y, Imase A, Arai S, Tamura Y, Tanemoto M, Uozaki H, Yamaguchi Y, Uchida S., Case Rep Nephrol. 2014;2014:569047., 2014年11月

Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-
共著, Ando K, Ohtsu H, Uchida S, Kaname S, Arakawa Y, Fujita T, for the EVALUATE Study Group., Lancet Diabetes Endocrinology 2014 Dec;2(12):944-953., 2014年12月

Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease
共著, Hosoya T, Ohno I, Nomura S, Hisatome I, Uchida S, Fujimori S, Yamamoto T, Hara S., Clin Exp Nephrol. 2014 Dec;18(6):876-884., 2014年12月

Combination of ACE inhibitor with nicorandil provides further protection in chronic kidney disease.
共著, Shiraishi T, Tamura Y, Taniguchi K, Higaki M, Ueda S, Shima T, Nagura M, Nakagawa T, Johnson RJ, Uchida S., Am J Physiol - Renal Physiol. 2014 Dec 15;307(12):F1313-F1322., 2014年12月

Acute Kidney Injury Facilitates Hypocalcemia by Exacerbating the Hyperphosphatemic Effect of Muscle Damage in Rhabdomyolysis.
共著, Higaki M, Tanemoto M, Shiraishi T, Taniguchi K, Fujigaki Y, Uchida S., Nephron. 2015;131(1):11-16., 2015年01月

Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the sh
共著, Muso E, Mune M, Hirano T, Hattori M, Kimura K, Watanabe T, Yokoyama H, Sato H, Uchida S, Wada T, Shoji T, Yuzawa Y, Takemura T, Sugiyama S, Nishizawa Y, Ogahara S, Yorioka N, Sakai S, Ogura, Clin Exp Nephrol. 2015 Jun;19(3):379-386., 2015年06月

Blood pressure control and satisfaction of hypertensive patients following a switch to combined drugs of an angiotensin recepto
共著, Kato H, Shiraishi T, Ueda S, Kubo E, Shima T, Nagura M, Yano H, Izumikawa Y, Shimada M, Tomioka S, Nosaka H, Kojima K, Tanemoto M, Uchida S., Clin Exp Nephrol. 2015 Jun;19(3):465-473., 2015年06月

Predictors and the subsequent risk of end-stage renal disease ?Usefulness of 30% decline in estimated GFR over 2 years.
共著, Chang WX, Asakawa S, Toyoki D, Nemoto Y, Morimoto C, Tamura Y, Ota T, Shibata S, Fujigaki Y, Shen ZY, Uchida S., PLoS One. 2015 Jul 15;10(7):e0132927., 2015年07月

A prospective observational survey on the long-term effect of LDL apheresis on drug-resistant nephrotic syndrome.
共著, Muso E, Mune M, Hirano T, Hattori M, Kimura K, Watanabe T, Yokoyama H, Sato H, Uchida S, Wada T, Shoji T, Takemura T, Yuzawa Y, Ogahara S, Sugiyama S, Iino Y, Sakai S, Ogura Y, Yukawa S, Nis, Nephron Extra. 2015 Aug 29;5(2):58-66., 2015年08月

Sonographic detection of a radiolucent object in dialysis vascular access.
共著, Tanemoto M, Higaki M, Amano K, Toyoki D, Arai S, Tomioka S, Uchida S., J Clin Ultrasound. 2015 Jul-Aug;43(6):397-399., 2015年08月

Sonographic detection of a radiolucent object in dialysis vascular access.
共著, Tanemoto M, Higaki M, Amano K, Toyoki D, Arai S, Tomioka S, Uchida S., J Clin Ultrasound. 2015 Jul-Aug;43(6):397-399., 2015年08月

ENOS deficiency causes podocyte injury with mitochondrial abnormality.
共著, Ueda S, Ozawa S, Mori K, Asanuma K, Yanagita M, Uchida S, Nakagawa T., Free Radic Biol Med. 2015 Oct;87:181-192., 2015年10月

Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: r
共著, Hayashi M, Uchida S, Kawamura T, Kuwahara M, Nangaku M, Iino Y, PROTECT-CKD Study Group., Clin Exp Nephrol. 2015 Oct;19(5):925-932., 2015年10月

Long-term efficacy of vildagliptin in patients with type 2 diabetes undergoing hemodialysis.
共著, Mera J, Okada E, Okuda M, Ota T, Sibata S, Uchida S., J Diabetes Metab Disord. 2015 Nov 5;14:83., 2015年11月

Rapid deterioration of the renal function caused by the coexistence of intratubular amyloidosis and myeloma cast nephropathy.
共著, Kato H, Fujigaki Y, Asakawa S, Yamaguchi Y, Uozaki H, Komatsuda A, Nagata M, Uchida S., Intern Med. 2015;54(23):3023-3028., 2015年12月

Targeting uric acid and the inhibition of progression to end-stage renal disease －A propensity score analysis.
共著, Uchida S, Chang WX, Ota T, Tamura Y, Shiraishi T, Kumagai T, Shibata S, Fujigaki Y, Hosoyamada M, Kaneko K, Shen ZY, Fujimori S., PLoS One. 2015 Dec 23;10(12):e0145506., 2015年12月

Time-dependent risk factors associated with the decline of estimated GFR in CKD patients.
共著, Chang W-X, Arai S, Tamura Y, Kumagai T, Ota T, Shibata S, Fujigaki Y, Shen ZY, Uchida S., Clin Exp Nephrol. 2016 Feb;20(1):58-70., 2016年02月

The impact of normal range of serum phosphorus on the incidence of end-stage renal disease by a propensity score analysis.
共著, Chang W-X, Xu N, Kumagai T, Shiraishi T, Kikuyama T, Omizo H, Sakai K, Arai S, Tamura Y, Ota T, Shibata S, Fujigaki Y, Shen Z-Y, Uchida S., PLoS One. 2016 Apr 28;11(4):e0154469., 2016年04月

Proteomics approach identifies factors associated with the response to LDL apheresis therapy in patients with steroid-resistant
共著, Kuribayashi-Okuma E, Shibata S, Arai S, Ota T, Watanabe S, Hisaki H, Okazaki T, Toda T, Uchida S., Ther Apher Dial 2016 Apr;20(2):174-182., 2016年04月

Pathological implications of linear immunoglobulin G staining on the glomerular capillary walls in a case of infection-related
共著, Fujigaki Y, Kawamorita Y, Yamaguchi H, Arai S, Tamura Y, Ota T, Shibata S, Kondo F, Yamaguchi Y, Uchida S., Pathol Int. 2016 Sep;66(9):524-528., 2016年09月

Potassium depletion stimulates Na-Cl cotransporter via phosphorylation and inactivation of the ubiquitin ligase Kelch-like 3.
共著, Ishizawa K, Xu N, Loffing J, Lifton R P, Fujita T, Uchida S, Shibata S., Biochem Biophys Res Commun. 2016 Nov;480(4):745-751., 2016年11月

Immunohistochemical and in situ hybridization study of urate transporters GLUT9/URATv1, ABCG2, and URAT1 in the murine brain.
共著, Tomioka NH, Tamura Y, Takada T, Shibata S, Suzuki H, Uchida S, Hosoyamada M., Fluids Barriers CNS. 2016 Dec 12;13(1):22., 2016年12月

Uric acid metabolism of kidney and intestine in a rat model of chronic kidney disease.
共著, Nagura, M, Tamura Y, Kumagai T, Hosoyamada M, Uchida S., Nucleosides Nucleotides Nucleic Acids. 2016 Dec;35(10-12):550-558., 2016年12月

Urat1-Uox double knockout mice are experimental animal models of renal hypouricemia and exercise-induced acute kidney injury.
共著, Hosoyamada M, Tsurumi Y, Hirano H, Tomioka N, Sekine Y, Morisaki T, Uchida S., Nucleosides Nucleotides Nucleic Acids. 2016 Dec;35(10-12):543-549., 2016年12月

Stimulation of V1a receptor increases renal uric acid clearance via urate transporters: Insight into pathogenesis of hypouricem
共著, Taniguchi K, Tamura Y, Kumagai T, Shibata S, Uchida S., Clin Exp Nephrol. 2016 Dec;20(6):845-852., 2016年12月

Podocyte injury and albuminuria in experimental hyperuricemic model rats.
共著, Asakawa S, Shibata S, Morimoto C, Shiraishi T, Nakamura T, Tamura Y, Kumagai T, Hosoyamada M, Uchida S., Oxid Med Cell Longev. 2017;2017:3759153., 2017年02月

Factors associated with unemployment in patients undergoing hemodialysis: a mixed methods study.
共著, Tsutsui H, Nomura K, Ishiguro A, Tsuruta Y, Kato S, Yasuda Y, Uchida S, Oshida Y., Renal Replacement Therapy. 2017;3:23., 2017年03月

Mineralocorticoid receptor as a therapeutic target in chronic kidney disease and hypertension.
共著, Shibata S, Ishizawa K, Uchida S., Hypertens Res. 2017 Mar;40(3):221-225., 2017年03月

Targeting gene expression to specific cells of kidney tubules in vivo, using adenoviral promoter fragments.
共著, Watanabe S, Ogasawara T, Tamura Y, Saito T, Ikeda T, Suzuki N, Shimosawa T, Shibata S, Chung U, Nangaku M, Uchida S., PLoS One. 2017 Mar 2;12(3):e0168638., 2017年03月

Time to target uric acid to retard CKD progression.
共著, Kumagai T, Ota T, Tamura Y, Chang WX, Shibata S, Uchida S., Clin Exp Nephrol. 2017 Apr;21(2):182-192., 2017年04月

Hypokalemia and pendrin induction by aldosterone.
共著, Xu N, Hirohama D, Ishizawa K, Chang W-X, Shimosawa T, Fujita T, Uchida S, Shibata S., Hypertension. 2017 May;69(5):855-862., 2017年05月

Renoprotective effect of topiroxostat via antioxidant activity in puromycin aminonucleoside nephrosis rats.
共著, Kawamorita Y, Shiraishi T, Tamura Y, Kumagai T, Shibata S, Fujigaki Y, Hosoyamada M, Nakagawa T, Uchida S., Physiol Rep. Vol. 5 no. e13358, 2017年05月

Insulin stimulates uric acid reabsorption via regulating urate transporter 1 and 1 ATP-binding cassette sub-family G member 2.
共著, Toyoki D, Shibata S, Kuribayashi-Okuma E, Xu N, Ishizawa K, Hosoyamada M, Uchida S., Am J Physiol - Renal Physiol. 2017 Sep 1;313(3):F826-F834., 2017年09月

Unique proximal tubular cell injury and the development of acute kidney injury in adult patients with minimal change nephrotic
共著, Fujigaki Y, Tamura Y, Nagura M, Arai S, Ota T, Shibata S, Kondo F, Yamaguchi Y, Uchida S., BMC Nephrol.2017;18(1):339., 2017年11月

Uric acid in the follow-up determines 30% decline in estimated GFR over 2 years: A propensity score analysis.
共著, Chang W-X, Xu N, Kumagai T, Iijima R, Waki K, Yamanaka M, Nagura M, Arai S, Tamura Y, Shibata S, Fujigaki Y, Uchida S., Kidney & Blood Pressure Res. 2017;42:1073-1087., 2017年12月

Association of cholesterol efflux capacity with plasmalogen levels of high-density lipoprotein: a cross-sectional study in chro
共著, 最終著者, Maeba R, Kojima K, Nagura M, Komori A, Nishimukai M, Okazaki T, Uchida S., Atherosclerosis. 2018;270:102-109., 2018年02月

Clinical presentation of tubulointerstitial nephritis caused by amyloid light-chain amyloidosis in a patient with Sj?gren’s syndrome.
共著, |, 最終著者, Inoue R, Fujigaki Y, Kobayashi K, Tamura Y, Ota T, Shibata S, Ishida T, Kondo F, Yamaguchi Y, Uchida S., Intern Med. 2017;56(4):419-423., 56, 4, 419, 423, 2017年04月
URL

A rare adult case with diffuse segmental membranous glomerulonephritis.
Fujigaki Y, Tamura Y, Shibata S, Kondo F, Iwakura T, Kojima K, Yamaguchi Y, Uchida S.,  Intern Med. 2017;56(13):1691-1695., 2017年07月
URL

Emergence of smoldering ANCA-associated glomerulonephritis during the clinical course of mixed connective tissue disease and Sj?gren’s syndrome.
Morimoto C, Fujigaki Y, Tamura Y, Ota T, Shibata S, Asako K, Kikuchi H, Kono H, Kondo F, Yamaguchi Y, Uchida S.,  Intern Med. 2018 Jun 15;57(12):1757-1762., 2018年06月
URL

Discontinuation of hemodialysis in a patient with anti-GBM disease by the treatment with corticosteroids and plasmapheresis despite several predictors for dialysis-dependence.
Fujigaki Y, Morimoto C, Iino R, Taniguchi K, Kawamorita Y, Asakawa S, Toyoki D, Miyano S, Fujii W, Ota T, Shibata S, Uchida S., Case Rep Nephrology. 2017;2017:7143649., 2017年11月
URL

Remission of refractory ascites and discontinuation of hemodialysis after additional rituximab to long-term glucocorticoid therapy in a patient with TAFRO syndrome.
共著, 最終著者, Tsurumi H, Fujigaki Y, Yamamoto T, Iino R, Taniguchi K, Nagura M, Arai S, Tamura Y, Ota T, Shibata S, Kondo F, Kurose N, Masaki Y, Uchida S., Intern Med. 2018 May 15;57(10):1433-1438. , 2018年05月
URL

Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.
共著, Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, et al., Clin Exp Nephrol. 2018 Dec;22(6):1266-1280., 2018年12月
URL

Urinary exosomal aquaporin-2 expression and the efficacy of tolvaptan in advanced CKD patients with congestive heart failure－An interim report.
最終著者|責任著者, Kodaka K, Kuribayashi-Okuma E, Arai S, Nagura M, Tamura Y, Shibata S, Fujigaki Y, Uchida S., J Clin Exp Nephrol 2018;3(1):57., 2018年01月
URL

A patient presenting with isolated hematuria and renal dysfunction as rare manifestation of cryoglobulinemic glomerulonephritis in the course of autoimmune diseases including Sjögren’s syndrome.
最終著者, Yamanaka M, Fujigaki Y, Kono H, Nagura M, Arai S, Tamura Y, Ota T, Shibata S, Kondo F, Yamaguchi Y, Uchida S., CEN Case Reports. 2018 Nov;7(2):211-216., 2018年11月
URL

ULK1 phosphorylates and regulates mineralocorticoid receptor.
共著, Shibata S, Ishizawa K, Wang Q, Xu N, Fujita T, Uchida S, Lifton RP.,  Cell Rep. 2018 Jul 17;24(3):569-576., 2018年07月
URL

Relationship between Xanthine Oxidoreductase Redox and Oxidative Stress among Chronic Kidney Disease Patients.
共著, Terawaki H, Hayashi T, Murase T, Iijima R, Waki K, Tani Y, Nakamura T, Yoshimura K, Uchida S, Kazama JJ., Oxid Med Cell Longev. 2018 Jul 8;2018:9714710., 2018年07月
URL

Febuxostat Therapy for Patients with Chronic Kidney Disease Stage 3 Involving Asymptomatic Hyperuricemia: A Randomized Trial.
共著, Kimura K, Hosoya T, Uchida S, Inaba M, Makino H, Maruyama S, Ito S, Yamamoto T, Tomino Y, Ohno I, Shibagaki Y, Iimuro S, Imai N, Kuwabara M, Hayakawa H, Ohtsu H, Ohashi Y, for the FEATHER Study Investigators, Am J Kidney Dis. 2018 Dec;72(6):798-810., 2018年12月
URL

The Association of Longitudinal Serum Uric Acid and All-Cause Mortality in Incident Peritoneal Dialysis Patients.
共著, Chang W, Zhang W, Wang X, Liu Y, Han Y, Tu Y, Uchida S.,  Blood Purif. 2019;47(1-3):185-192., 2019年03月, 有り, 英語, 研究論文（学術雑誌）, 国際誌, 国際共著している
URL

Defective glycosylation of α-dystroglycan contributes to podocyte flattening.
共著, 最終著者|責任著者, Kojima K, Nosaka H, Kishimoto Y, Nishiyama Y, Fukuda S, Shimada M, Kodaka K, Saito F, Matsumura K, Shimizu T, Toda T, Takeda S, Kawachi H, Uchida S., Kidney Int. 2011 Feb;79(3):311-6., 2011年02月, 有り, 英語, 研究論文（学術雑誌）, 国際誌
URL

Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate.
共著, Jutabha P, Anzai N, Kitamura K, Taniguchi A, Kaneko S, Yan K, Yamada H, Shimada H, Kimura T, Katada T, Fukutomi T, Tomita K, Urano W, Yamanaka H, Seki G, Fujita T, Moriyama Y, Yamada A, Uchida S, Wempe MF, Endou H, Sakurai H., J Biol Chem. 2010 Nov 5;285(45):35123-32., 2010年11月, 有り, 英語, 研究論文（学術雑誌）, 国際誌, 国際共著している
URL

Increased Na reabsorption via the Na-Cl cotransporter in autosomal recessive pseudohypoaldosteronism.
共著, 最終著者, Adachi M, Asakura Y, Muroya K, Tajima T, Fujieda K, Kuribayashi E, Uchida S., Clin Exp Nephrol. 2010 Jun;14(3):228-32., 2010年06月, 有り, 英語, 研究論文（学術雑誌）, 国際誌, 国際共著していない
URL

Podocyte foot process effacement in very early phase of passive Heymann nephritis is not a prerequisite for proteinuria.
Nosaka H, Tamura Y, Kojima K, Uchida S, Nagase M., J Nephrol. 2009 Jul-Aug;22(4):484-90., 2009年08月, 有り, 英語, 国際誌, 国際共著していない
URL

Treatment for hyperkalemia in hyporeninemic hypoaldosteronism. Response.
共著, Takemoto F, Takaichi K, Uchida S., Kidney Int. 2009; 75(10):1113-1114., 2009年10月, 有り, 英語, 研究論文（学術雑誌）, 国際誌, 国際共著していない
URL

Clinical practice guidebook for diagnosis and treatment of chronic kidney disease.
共著, Matsuo S, Watanabe T, Iino Y, Uchida S, Iseki K, Imai E, Kimura K, Tsukamoto Y, Nitta K, Hara S, Matsuyama T, Moriyama T, Yamagata K, Yasuda Y, Ando Y, Ito S, Uemura O, Kato T, Kimura G, Nakao T, Hattori M, Fukagawa M, Horio M, Mitarai T, Committee of CKD Initiative, Japanese Society of Nephrology., Clin Exp Nephrol. 13: 187-248, 2009., 2009年03月, 有り, 有り, 英語, 研究論文（学術雑誌）, 国際誌, 国際共著していない
URL

Plasma adiponectin: a predictor of coronary heart disease in hemodialysis patients--a Japanese prospective eight-year study.
共著, 最終著者, Takemoto F, Katori H, Sawa N, Hoshino J, Suwabe T, Nakanishi S, Arai S, Fukuda S, Kodaka K, Shimada M, Yamazaki C, Yokoyama K, Nakano Y, Funahashi T, Ubara Y, Yamada A, Takaichi K, Uchida S., Nephron Clin Pract. 2009;111(1):c12-20., 2009年01月, 有り, 英語, 研究論文（学術雑誌）, 国際誌, 国際共著していない
URL

A Patient with MPO-ANCA-positive IgA Nephropathy Diagnosed with the Clinical Onset of Macrohematuria.


共著, Yasukawa M, Kitagawa S, Togashi R, Asakawa S, Nagura M, Arai S, Yamazaki O, Tamura Y, Kondo F, Ohashi R, Uchida S, Shibata S, Fujigaki Y., Intern Med. 2019 Jul 15;58(14):2051-2056., 2019年07月, 有り, 無し, 英語, 研究論文（学術雑誌）, 国際誌, 国際共著していない
URL

Phosphate binding by sucroferric oxyhydroxide ameliorates renal injury in the remnant kidney model.
Nemoto Y, Kumagai T, Ishizawa K, Miura Y, Shiraishi T, Morimoto C, Sakai K, Omizo H, Yamazaki O, Tamura Y, Fujigaki Y, Kawachi H, Kuro-O M, Uchida S, Shibata S., Sci Rep. 2019 Feb 11;9(1):1732., 2019年02月, 有り, 無し, 英語, 研究論文（学術雑誌）, 国際誌, 国際共著していない
URL

25(OH)D₃ stimulates the expression of vitamin D target genes in renal tubular cells when Cyp27b1 is abrogated.

Kikuyama T, Susa T, Tamamori-Adachi M, Iizuka M, Akimoto M, Okinaga H, Fujigaki Y, Uchida S, Shibata S, Okazaki T., J Steroid Biochem Mol Biol. 2020 May;199:105593., 2020年05月, 有り, 無し, 英語, 研究論文（学術雑誌）, 国際誌, 国際共著していない
URL

Decline in serum uric acid predicts higher risk for mortality in peritoneal dialysis patients-a propensity score analysis.
Chang W, Uchida S, Qi P, Zhang W, Wang X, Liu Y, Han Y, Li J, Xu H, Hao J., J Nephrol. 2020 Jun;33(3):591-599., 2020年06月, 有り, 無し, 英語, 研究論文（学術雑誌）, 国際誌, 国際共著している
URL

Cardio-renal protective effect of the xanthine oxidase inhibitor febuxostat in the 5/6 nephrectomy model with hyperuricemia.
共著, Omizo H, Tamura Y, Morimoto C, Ueno M, Hayama Y, Kuribayashi-Okuma E, Uchida S, Shibata S., Sci Rep. 2020 Jun 9;10(1):9326., 2020年06月, 有り, 無し, 英語, 研究論文（学術雑誌）, 国際誌, 国際共著していない
URL

ABCG2 expression and uric acid metabolism of the intestine in hyperuricemia model rat.
Morimoto C, Tamura Y, Asakawa S, Kuribayashi-Okuma E, Nemoto Y, Li J, Murase T, Nakamura T, Hosoyamada M, Uchida S, Shibata S.

, Nucleosides Nucleotides Nucleic Acids. 2020;39(5):744-759., 2020年05月, 有り, 無し, 英語, 研究論文（学術雑誌）, 国際誌, 国際共著していない
URL

A Ruptured Jejunal Arterial Aneurysm in a Young Woman Undergoing Chronic Hemodialysis Due to Myeloperoxidase-antineutrophil Cytoplasmic Antibody-associated Vasculitis.
Murakawa M, Arai S, Kawagoe M, Tomomitsu Y, Odajima K, Ueno M, Asakawa S, Hirohama D, Nagura M, Yamazaki O, Tamura Y, Uchida S, Shibata S, Fujigaki Y., Intern Med. 2021 Sep 15;60(18):2939-2945., 2021年09月, 有り, 無し, 英語, 研究論文（学術雑誌）, 国際誌
URL

Incidence and factors associated with prescribing renin-angiotensin-system inhibitors in adult idiopathic nephrotic syndrome: A nationwide cohort study.

共著,

Nishiwaki H, Niihata K, Shimizu S, Shibagaki Y, Yamamoto R, Nitta K, Tsukamoto T, Uchida S, Takeda A, Okada H, Narita I, Isaka Y, Kurita N; Japan Nephrotic Syndrome Cohort Study group.

,

J Clin Hypertens (Greenwich). 2021 May;23(5):999-1007.

, 2021年05月, 有り, 無し, 英語, 研究論文（学術雑誌）, 国際誌, 国際共著していない
URL

Hyperkalemia in patients undergoing hemodialysis: Its pathophysiology and management.

共著, 最終著者,

Shibata S, Uchida S.

,

Ther Apher Dial. 2022 Feb;26(1):3-14.

, 2022年02月, 有り, 無し, 英語, 研究論文（学術雑誌）, 国際誌, 国際共著していない
URL

SLC23A3 is a renal hypoxanthine transporter.

Hosoyamada M, Tomioka NH, Watanabe T, Yasuno N, Uchida S, Shibata S., Nucleosides Nucleotides Nucleic Acids. 2022 Jan 30:1-8., 2022年01月, 有り, 無し, 英語, 研究論文（学術雑誌）, 国際誌, 国際共著していない
URL

Perfecting a high hypoxanthine phosphoribosyltransferase activity-uricase KO mice to test the effects of purine- and non-purine-type xanthine dehydrogenase (XDH) inhibitors.
Hosoya T, Uchida S, Shibata S, Tomioka NH, Hosoyamada M., Br J Pharmacol. 2020 May;177(10):2274-2285., 2020年05月, 有り, 無し, 英語, 研究論文（学術雑誌）, 国際誌, 国際共著していない
URL

Xanthine Oxidoreductase Inhibitors Suppress the Onset of Exercise-Induced AKI in High HPRT Activity Urat1-Uox Double Knockout Mice.

Hosoya T, Uchida S, Shibata S, Tomioka NH, Matsumoto K, Hosoyamada M., J Am Soc Nephrol. 2022 Feb;33(2):326-341., 2022年02月, 有り, 無し, 英語, 研究論文（学術雑誌）, 国際誌, 国際共著していない
URL

Association Between Serum Uric Acid and Depression in Patients with Chronic Kidney Disease not Requiring Kidney Dialysis: Cross-Sectional and Longitudinal Analyses.
共著, Bin Gao, Xinyuan Song, Jie Hao, Yingying Han, Miaomiao Zhang, Na Sun, Jinping Li, Pingping Qi, Shunya Uchida, Wenxiu Chang, Med Sci Monit. 2020 Sep 27;26:e925386., 2020年09月, 有り, 無し, 英語, 研究論文（学術雑誌）, 国際誌, 国際共著している
URL

Effect of uric acid-lowering therapy on renal function in patients with chronic kidney disease: a systematic review and meta-analysis.
共著, 最終著者, Yukio Maruyama, Takanori Kumagai, Naoki Sugano, Shigetaka Yoshida, Kimiyoshi Ichida, Shunya Uchida, Renal Replacement Therapy 2021 Aug. 7(1):44., 2021年08月, 有り, 無し, 英語, 研究論文（学術雑誌）, 国際誌, 国際共著していない
URL

Prediction of Chronic Kidney Disease Progress Based on Two-Dimensional Convolutional Neural Networks.

Tingting Yang, Wenyu Zhang, Kunpeng Xie, Shunya Uchida, Wenxiu Chang

, SSRN (Social Science Research Network), 2022年03月, 無し, 無し, 英語, 研究論文（国際会議プロシーディングス）, 国際誌, 国際共著している
URL

CONTRIBUTIONS TO NEPHROLOGY
共著, Uchida S, Kumagai T, Chang W X, Tamura Y, Shibata S. Time to target uric acid to retard CKD progression. Editors: Alejandro Trevi?o Becerra (Mexico City, Mexico) and Kunitoshi Iseki (Ok, Kargar AG, 2018年01月